In the case of the dynamic inflammation level alterations in different retinopathy stages, clinical studies showed that serum IL-6 was significantly increased in both the nonproliferative DR and proliferative DR but not in no DR patients with T2DM [26, 41]. Here, IL6 is linked to retinal disorder.